.Merck beats profits assumptions, increases sales expectation on tough need for leading medicines like Keytruda CNBCMerck & Co. (MRK US) Beats Income Forecasts as Keytruda Sales Growth BloombergMerck Sell: Pharma Titan Posts Powerful End Results, However Expectation Drops Short Client's Company DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps revenue and sales desires in the middle of Keytruda strength, yet delivers mixed full-year overview MarketWatch.